Table 1.
Major targeted pathways | Compounds | PAH-specific drugs | Administration routes | The side effects and damages
|
||
---|---|---|---|---|---|---|
Related to the administration routes | Related to the pharmacological action
|
|||||
More frequent | Others | |||||
Endothelin pathway | ERAs | Bosentan | Oral | – | Liver transaminase elevation | Flushing, headaches dizziness, peripheral edema, palpitations, chest pain, nasopharyngitis, anemia |
Ambrisentan | Oral | – | Peripheral edema | Nasal congestion, upper respiratory tract infection, nausea, sinusitis, nasopharyngitis, flushing, headaches, liver transaminase elevation, abdominal pain, constipation, palpitations, dyspnea | ||
Macitentan | Oral | – | Headaches, nasopharyngitis, anemia | Peripheral edema, anemia, upper respiratory tract infection, dizziness, bronchitis, dyspnea, cough, liver transaminase elevation | ||
Sitaxentan* | Oral | – | Acute liver toxicity | Nasal congestion, flushing | ||
Nitric oxide-cGMP pathway | PDE-5 inhibitors | Sildenafil | Oral | – | Headaches, flushing, epistaxis | Left ventricular dysfunction, postural hypotension, dyspepsia, back pain, diarrhea, extremity pain, myalgia, cough, pyrexia, insomnia, influenza, visual disturbance, grand mal seizure, drug hypersensitivity, urticaria, angioedema, gastroesophageal reflux disease, posterior subcapsular cataract, neck stiffness, abdominal pain |
Intravenous | – | Flushing | Flatulence, hypotension, syncope | |||
Tadalafil | Oral | – | Headaches, myalgia, flushing | Diarrhea, nausea, back pain, dyspepsia, dyspnea, extremity pain, muscle spasms, upper respiratory tract infection, epistaxis, palpitations, arthralgia, chest pain, vomiting, fatigue, nasal congestion, edema, bronchitis, insomnia, urinary tract infection, blurred vision | ||
sGC stimulators | Riociguat | Oral | – | Headaches, flushing, hypotension | Dyspepsia, peripheral edema, nausea, syncope, bleeding (including hemoptysis), dizziness, diarrhea, vomiting, nasopharyngitis, anemia, palpitations, chest pain, dyspnea, gastroesophageal reflux disease, cough, nasal congestion, pyrexia, fatigue, chest discomfort, gastritis | |
Prostacyclin pathway | Prostacyclin analogs | Epoprostenol | Continuous intravenous infusion | Catheter-related infections, sepsis, thromboembolic event, irritation, bleeding, drug-delivery system malfunction | Jaw pain, diarrhea, flushing | Headaches, nausea, vomiting |
Iloprost | Inhaled | Increased cough | Flushing, jaw pain, headaches | Hypotension, influenza-like syndrome, peripheral edema, nausea, diarrhea, dizziness | ||
Treprostinil | Oral | – | Headaches, flushing, nausea | Diarrhea, jaw pain, vomiting, extremity pain | ||
Continuous subcutaneous infusion | Severe infusion site pain, reaction, bleeding and bruising | Diarrhea, jaw pain, flushing | Peripheral edema, nausea, rash, dizziness, vomiting, headaches, vasodilatation | |||
Continuous intravenous infusion | Catheter-related blood stream infection, thromboembolic event, irritation, bleeding, drug-delivery system malfunction | Extremity pain, headaches, diarrhea | Jaw pain, nausea, fatigue, loose stools, vomiting, dizziness, dyspnea, flushing, palpitations, peripheral edema | |||
Inhaled | Cough, throat irritation, | Headaches, nausea, | Flushing, diarrhea, anemia, abdominal pain, diabetes mellitus, | |||
pharyngolaryngeal pain | dizziness | gastric ulcer | ||||
Beraprost | Oral | – | Headaches, flushing, jaw pain | Diarrhea, extremity pain, nausea, pharyngitis, asthenia, palpitations, vasodilatation |
Note:
Sitaxentan was withdrawn from the market in 2010 because of an increasing number of deaths attributed to acute liver toxicity. –, not applicable.
Abbreviation: PAH, pulmonary arterial hypertension.